TGTX-111

N/A

Report date: 2024/05/31 17:22:15

Base Information

Drug NameTGTX-111
Drug Alias NameTGTX-111TSHA-111TSHA-111-LAFORINTSHA-111-MALIN
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGlycogen synthase 1 inhibitorsGene transference
TargetsGlycogen synthase 1
Therapy Area/IndicationsLafora Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesTaysha Gene Therapies Inc
Inactive CompaniesN/A
Active IndicationsLafora Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A